Based on these findings, we suggest that serum YKL-40 may be a useful initial screening tool or follow-up risk indicator for lipid abnormalities, atherosclerosis, and CVD in children and adolescents with risk factors, regardless of obesity. The gene discussed is CHI3L1; the disease is Obesity.